The Sex-Frailty Paradox in Heart Attacks: Why Frail Men Die at Higher Rates

The debate about sex disparities in heart attack care has, until now, largely centered on a documented problem: women are systematically undertreated compared to men after acute myocardial infarction. They are less likely to receive guideline-recommended medications, less likely to undergo invasive procedures, and tend to wait longer before diagnosis. Addressing that disparity has been a legitimate and ongoing focus for cardiologists worldwide.

A large study from the University of Leicester, published in The Lancet Regional Health - Europe, complicates that picture without undermining it. The research, which analyzed national UK data on more than 900,000 heart attack patients over 15 years, identifies a hidden and previously unquantified vulnerability among men - one that current treatment approaches are not addressing effectively.

Frailty Is Common in Women, But More Fatal in Men

The central finding is what the researchers term a "sex-frailty paradox." Among patients who suffer a heart attack, severe frailty is indeed more common in women. That part of the picture was already broadly understood - women who experience acute myocardial infarction tend to be older and more frail at the time of their event. What had not been systematically examined was whether the consequence of frailty differed between sexes.

It does, substantially. After accounting for differences in treatment and baseline characteristics, frail men with acute myocardial infarction faced a significantly higher probability of dying within one year than frail women. This disparity persisted even though frail men received more intensive therapeutic interventions than frail women - consistent with existing evidence on sex-based treatment differences. Additional treatment intensity did not overcome the higher mortality risk in frail men.

The study was led by Dr. Muhammad Rashid from the University of Leicester's Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, alongside Dr. Hasan Mohiaddin and Horatio Mosanya. It drew on 15 years of national registry data, making it the largest analysis of frailty and sex interactions in heart attack outcomes to date.

Different Biology Behind Frailty in Each Sex

Why would frailty predict worse outcomes in men than women, even with more aggressive treatment? The researchers propose that frailty may represent fundamentally different underlying conditions in the two sexes.

In men, existing evidence suggests that frailty following a heart attack tends to reflect severe coronary artery disease with advanced atherosclerosis, a higher prevalence of diabetes, and the presence of multiple cardiovascular conditions simultaneously. Men's hearts in this state have diminished physiological reserves - the capacity to withstand another major cardiac event or to recover from the initial infarction is compromised at a fundamental biological level. Even when life-saving procedures are performed, the underlying vulnerability of the cardiovascular system persists.

In women, frailty appears to reflect something different: multi-system decline that is not primarily driven by the severity of coronary disease. Women's frailty, the researchers suggest, may be a marker of accumulated disability across multiple organ systems - a whole-body state of reduced reserve rather than a specifically cardiac one. This distinction matters for treatment: interventions targeted at the heart may address the dominant problem in frail men but miss the broader multi-system picture in frail women.

Current Risk Tools Don't Capture This Interaction

Clinical risk assessment for heart attack patients typically uses composite scoring systems that incorporate age, frailty, and comorbidities to guide treatment decisions. The university Leicester analysis shows that these tools treat frailty as a uniform predictor of poor outcomes regardless of sex - which this data contradicts.

If a frail man and a frail woman with similar frailty scores are at fundamentally different levels of one-year mortality risk, then a single score applied uniformly to both will either overtreat one or undertreat the other. Developing sex-specific frailty assessment tools that account for the different biology underlying frailty in men and women would allow for more precise risk stratification and more targeted interventions.

Dr. Rashid emphasized that the findings do not diminish the documented problem of women receiving inadequate treatment after heart attacks. They add a second problem running in parallel: frail men receive intensive treatment but still die at higher rates. Both issues require attention, and the solutions for each are likely to be different.

Limitations and Next Steps

The study is retrospective and observational, drawing on registry data rather than a controlled trial. While the 15-year national dataset is large enough to detect robust associations, residual confounding - unmeasured differences between patient groups that could explain part of the mortality gap - cannot be fully excluded. The frailty measures used in national registry data are also less granular than those obtainable in prospective clinical studies, which may mean some nuances in frailty severity are not fully captured.

The researchers call for the development and prospective validation of sex-specific frailty tools as a priority for future research. They also emphasize that equitable delivery of established therapies for women remains essential, and that the finding about frail men should not be used to justify reducing the focus on female undertreatment - both problems coexist and both warrant systematic solutions.

The research was conducted through collaboration between the University of Leicester, the Victor Phillip Dahdaleh Heart and Lung Research Institute at the University of Cambridge, and the Center for Geriatric Medicine at the Cleveland Clinic. Funding came from the NIHR and the British Heart Foundation Centre of Excellence.